Cocrystal Pharma Inc. Stock
Your prediction
Cocrystal Pharma Inc. Stock
We can see a decrease in the price for Cocrystal Pharma Inc.. Compared to yesterday it has lost -€0.010 (-1.410%).
For the coming years our community has positive and negative things to say abot the Cocrystal Pharma Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | -1.410% | -12.500% | -21.348% | -55.696% | -14.110% | -70.833% | -93.295% |
| Pacira Pharmaceuticals | 0.000% | -1.724% | 2.703% | 21.925% | 5.556% | -34.483% | -54.400% |
| Corcept Therapeutics Inc. | 0.260% | 22.242% | 25.500% | 64.219% | 43.229% | 242.448% | 438.132% |
| Supernus Pharmaceuticals | 0.000% | -3.500% | -7.656% | 26.974% | -10.233% | 33.103% | 70.796% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat